Skip to content
CIRI-IT
  • HOME-Eng
  • Organization
    • The Origins
    • The Scientific Committee
    • The Center’s Objectives
    • Future Perspectives
  • Research
    • Study on RSV epidemiology and impact: RESPIRA 50
    • RSV ComNet Project
    • EPSS Studies
    • ID.DRIVE
  • Publications
  • News_En
    • Nirsevimab: a new opportunity for RSV prevention in newborns
    • Sexually transmitted diseases
    • Prevention and control of Influenza in the 2024–2025 season
  • Contacts
    • Newsletter
  • NVPP 2023–2025
  • Toggle website search
Search this website
Menu Close
  • HOME-Eng
  • Organization
    • The Origins
    • The Scientific Committee
    • The Center’s Objectives
    • Future Perspectives
  • Research
    • Study on RSV epidemiology and impact: RESPIRA 50
    • RSV ComNet Project
    • EPSS Studies
    • ID.DRIVE
  • Publications
  • News_En
    • Nirsevimab: a new opportunity for RSV prevention in newborns
    • Sexually transmitted diseases
    • Prevention and control of Influenza in the 2024–2025 season
  • Contacts
    • Newsletter
  • NVPP 2023–2025
  • Toggle website search
You are currently viewing Avian Influenza and the New mRNA Vaccine

Avian Influenza and the New mRNA Vaccine

You Might Also Like

Read more about the article 2030 Agenda for Sustainable Development

2030 Agenda for Sustainable Development

25 Jun 2025
Read more about the article Measles in Italy in 2025: between the Milan outbreak and national challenge

Measles in Italy in 2025: between the Milan outbreak and national challenge

25 Jun 2025
Read more about the article Nirsevimab: a new opportunity for RSV prevention in newborns

Nirsevimab: a new opportunity for RSV prevention in newborns

25 Jun 2025

Search

CM_EN

  • HOME-Eng
  • Organization
    • The Origins
    • The Scientific Committee
    • The Center’s Objectives
    • Future Perspectives
  • Research
    • Study on RSV epidemiology and impact: RESPIRA 50
    • RSV ComNet Project
    • EPSS Studies
    • ID.DRIVE
  • Publications
  • News_En
    • Nirsevimab: a new opportunity for RSV prevention in newborns
    • Sexually transmitted diseases
    • Prevention and control of Influenza in the 2024–2025 season
  • Contacts
    • Newsletter
  • NVPP 2023–2025

Restricted Area

  • Accesso
© Copyright 2023 - CIRI-IT InterUniversity Research Center on Influenza

SPECIALE COVID-19

Lorem ipsum dolor sit amet, consectetur adipiscing elit. In pulvinar erat ut venenatis maximus. Duis varius fermentum imperdiet. Morbi ipsum odio, ultricies non diam et, consectetur auctor lacus. Nunc a mi tellus. Nullam sit amet urna imperdiet, malesuada enim et, rutrum libero. Donec vel orci quis felis dapibus lobortis et at diam. Suspendisse at vehicula risus, maximus pretium dolor. Duis congue dolor nec ante dapibus, et venenatis libero finibus. Donec in mattis est. Morbi euismod, metus at lobortis rhoncus, lacus arcu malesuada lectus, sed pharetra magna diam ut purus. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Integer quis lorem vulputate, elementum lacus non, porta ipsum.